181 related articles for article (PubMed ID: 30416791)
21. The prognosis of invasive adenocarcinoma presenting as ground-glass opacity on chest computed tomography after sublobar resection.
Moon Y; Lee KY; Park JK
J Thorac Dis; 2017 Oct; 9(10):3782-3792. PubMed ID: 29268386
[TBL] [Abstract][Full Text] [Related]
22. Prediction of the stage shift growth of early-stage lung adenocarcinomas by volume-doubling time.
Tang EK; Wu YJ; Chen CS; Wu FZ
Quant Imaging Med Surg; 2024 Jun; 14(6):3983-3996. PubMed ID: 38846271
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor mutations: effect on volume doubling time of non-small-cell lung cancer patients.
Nakamura R; Inage Y; Tobita R; Mori K; Numata T; Yanai H; Endo T; Ohtani H; Satoh H; Yuzawa K; Koizumi M; Ueki H
J Thorac Oncol; 2014 Sep; 9(9):1340-4. PubMed ID: 24481317
[TBL] [Abstract][Full Text] [Related]
24. Ground-glass opacity-featured lung adenocarcinoma has no response to chemotherapy.
Zhang Y; Deng C; Ma X; Gao Z; Wang S; Zheng Q; Xia G; Wen Z; Han H; Fu F; Liu Q; Hu H; Li Y; Wong KK; Chen H
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2411-2417. PubMed ID: 32356178
[TBL] [Abstract][Full Text] [Related]
25. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience.
Yamaguchi M; Furuya A; Edagawa M; Taguchi K; Shimamatsu S; Toyokawa G; Toyozawa R; Nosaki K; Hirai F; Seto T; Takenoyama M; Ichinose Y
Surg Oncol; 2015 Sep; 24(3):258-63. PubMed ID: 26298200
[TBL] [Abstract][Full Text] [Related]
26. Toward improving prognosis prediction in patients undergoing small lung adenocarcinoma resection: Radiological and pathological assessment of diversity and intratumor heterogeneity.
Koezuka S; Mikami T; Tochigi N; Sano A; Azuma Y; Makino T; Otsuka H; Matsumoto K; Shiraga N; Iyoda A
Lung Cancer; 2019 Sep; 135():40-46. PubMed ID: 31447001
[TBL] [Abstract][Full Text] [Related]
27. Adenocarcinomas with predominant ground-glass opacity: correlation of morphology and molecular biomarkers.
Aoki T; Hanamiya M; Uramoto H; Hisaoka M; Yamashita Y; Korogi Y
Radiology; 2012 Aug; 264(2):590-6. PubMed ID: 22653188
[TBL] [Abstract][Full Text] [Related]
28. Prediction of Surgical Outcome by Tumor Volume Doubling Time via Stereo Imaging Software in Early Non-Small Cell Lung Cancer.
Liu CC; Cheng YF; Ke PC; Chen YL; Lin CM; Wang BY
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568768
[TBL] [Abstract][Full Text] [Related]
29. [The correlation study of ground glass opacity and lepidic growth pattern component in stage I lung invasive adenocarcinoma].
Zhang L; Wu N; Li M; Sun W; Lyu L; Hou DH; Lin DM
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):269-273. PubMed ID: 28550666
[No Abstract] [Full Text] [Related]
30. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan.
Chang B; Hwang JH; Choi YH; Chung MP; Kim H; Kwon OJ; Lee HY; Lee KS; Shim YM; Han J; Um SW
Chest; 2013 Jan; 143(1):172-178. PubMed ID: 22797081
[TBL] [Abstract][Full Text] [Related]
31. Detection of lung cancer on chest radiographs: analysis on the basis of size and extent of ground-glass opacity at thin-section CT.
Tsubamoto M; Kuriyama K; Kido S; Arisawa J; Kohno N; Johkoh T; Tomiyama N; Honda O; Kuroda C
Radiology; 2002 Jul; 224(1):139-44. PubMed ID: 12091673
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.
Moon Y; Sung SW; Lee KY; Park JK
J Thorac Dis; 2016 Sep; 8(9):2562-2570. PubMed ID: 27747010
[TBL] [Abstract][Full Text] [Related]
33. Radiogenomic correlation in lung adenocarcinoma with epidermal growth factor receptor mutations: Imaging features and histological subtypes.
Hong SJ; Kim TJ; Choi YW; Park JS; Chung JH; Lee KW
Eur Radiol; 2016 Oct; 26(10):3660-8. PubMed ID: 26787602
[TBL] [Abstract][Full Text] [Related]
34. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
[TBL] [Abstract][Full Text] [Related]
35. Invasiveness and surgical timing evaluation by clinical features of ground-glass opacity nodules in lung cancers.
Chen PH; Chang KM; Tseng WC; Chen CH; Chao JI
Thorac Cancer; 2019 Nov; 10(11):2133-2141. PubMed ID: 31571421
[TBL] [Abstract][Full Text] [Related]
36. Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity.
Yoshida Y; Kokubu A; Suzuki K; Kuribayashi H; Tsuta K; Matsuno Y; Kusumoto M; Kanai Y; Asamura H; Hirohashi S; Shibata T
Jpn J Clin Oncol; 2007 Dec; 37(12):907-12. PubMed ID: 18089646
[TBL] [Abstract][Full Text] [Related]
37. Growth rate of small lung cancers detected on mass CT screening.
Hasegawa M; Sone S; Takashima S; Li F; Yang ZG; Maruyama Y; Watanabe T
Br J Radiol; 2000 Dec; 73(876):1252-9. PubMed ID: 11205667
[TBL] [Abstract][Full Text] [Related]
38. Ground-glass opacity on thin-section CT: value in differentiating subtypes of adenocarcinoma of the lung.
Kuriyama K; Seto M; Kasugai T; Higashiyama M; Kido S; Sawai Y; Kodama K; Kuroda C
AJR Am J Roentgenol; 1999 Aug; 173(2):465-9. PubMed ID: 10430155
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma.
Zhai W; Liang D; Duan F; Wong W; Yan Q; Gong L; Lai R; Dai S; Long H; Wang J
Front Cell Dev Biol; 2021; 9():769881. PubMed ID: 34957101
[TBL] [Abstract][Full Text] [Related]
40. Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes.
Lee HJ; Kim YT; Kang CH; Zhao B; Tan Y; Schwartz LH; Persigehl T; Jeon YK; Chung DH
Radiology; 2013 Jul; 268(1):254-64. PubMed ID: 23468578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
